Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Qirui Weishu capsule in chronic gastritis
ChiCTR2400081570Phase 4Recruiting
- Sponsor
- Wuxi People's Hospital
- Start
- Nov 2023
- Countries
- 1
01
Overview
Phase 4, open-label trial of 七蕊胃舒胶囊 in chronic gastritis, chronic non-atrophic gastritis, atrophic gastritis (AG) and 1 more (2 arms), sponsored by Wuxi People's Hospital. Primary endpoint: NRS score for abdominal pain. Started Nov 2023; status: recruiting.
02
Drugs
七蕊胃舒胶囊
03
Conditions
chronic gastritischronic non-atrophic gastritisatrophic gastritis (AG)Benign Gastric Ulcer (GU)
Beyond the preview
Go deeper on ChiCTR2400081570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081570.